Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Common Stock | Award | $112K | +25.5K | +46.97% | $4.42 | 79.6K | Jun 10, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Stock Option (right to buy) | Award | $0 | +48.5K | $0.00 | 48.5K | Jun 10, 2021 | Common Stock | 48.5K | $4.42 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date. |
F2 | Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. |
F3 | The options vest and become exercisable one year from the grant date. |